Trials / Completed
CompletedNCT03897413
Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult Volunteers
An Open-label, Randomized, Three-period, Crossover Study to Assess the Effect of Food and Calcium on S-888711 0.25-mg Tablet Pharmacokinetics in Healthy, Adult Volunteer Subjects Following a Single 0.75-mg Oral Dose of S-888711
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The primary objectives of this study were: * To assess the effect of a high-fat diet on the pharmacokinetics (PK) of a 0.75 mg single dose of S-888711 orally administered as 0.25 mg tablets in healthy volunteer adults * To assess the effect of a calcium supplement on the PK of a 0.75 mg single dose of S-888711 orally administered as 0.25 mg tablets in healthy volunteer adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-888711 | Administered orally as three 0.25 mg tablets |
| DIETARY_SUPPLEMENT | Calcium Antacid | Calcium carbonate 4000 mg chewable tablets |
Timeline
- Start date
- 2009-11-06
- Primary completion
- 2009-12-23
- Completion
- 2009-12-23
- First posted
- 2019-04-01
- Last updated
- 2019-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03897413. Inclusion in this directory is not an endorsement.